Sort   by:  
 Page size 
UnknownA phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
Not available
S-EPMC6602847 | biostudies-literature
UnknownNivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Not available
S-EPMC5972549 | biostudies-literature
UnknownClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Not available
S-EPMC7255743 | biostudies-literature
UnknownAssociation of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Not available
S-EPMC8377563 | biostudies-literature
UnknownRacial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
Not available
S-EPMC8961318 | biostudies-literature
UnknownA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
Not available
S-EPMC7598547 | biostudies-literature
UnknownAssessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
Not available
S-EPMC8728628 | biostudies-literature
Sort   by:  
 Page size